Targeted Drug Delivery in Rheumatoid Arthritis: Leveraging Collagen Hybridizing Peptides for Enhanced Therapeutic Efficacy
Histological staining of mouse tibia-talus joints showing healthier articular cartilage due to iFab-CHP treatment compared PBS placebo. Rheumatoid arthritis (RA) is a chronic autoimmune disease which leads to the breakdown of the cartilage in the synovial joints. Current treatment strategies with tumor necrosis factor-alpha (TNFa) targeting neutralizing antibodies effectively reduce...
View Details
Using Collagen Hybridizing Peptides to Improve IPF Diagnosis and Imaging
Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease marked by rapid progressive lung failure due to an accumulation of fibrotic collagen tissue. Due to the rapid onset of the disease, accurate and effective diagnostic tools are crucial for improving patient outcomes. Additionally, monitoring patient response to treatment should be minimally invasive...
View Details
Collagen Hybridizing Peptides Conjugated to Water-Soluble Copolymers for Targeting Intratibial Osteosarcoma
Discover innovative strategies for treating osteosarcoma (OS) with localized drug delivery using Collagen Hybridizing Peptides (CHPs). OS, a malignant bone cancer, often requires surgery and chemotherapy, but these treatments are plagued by systemic side effects. This research highlights the potential of CHPs to selectively target tumors by binding to damaged collagen in bone tissue.
View Details
Detecting Early Arterial Damage in Atherosclerosis: How Collagen Hybridizing Peptides Overcome Diagnostic Challenges
Atherosclerosis, characterized by the buildup of plaque inside human arteries, is one of the leading causes of cardiovascular diseases. The disease is brought on by a complex interplay between lipids, inflammatory cells, and the ECM. Arterial blood flow is restricted as plaques form, which can rupture to cause blockage. Arterial blockage, or occlusion, is...
View Details
Uncovering Fibrosis: Superior Sensitivity of CHPs in Targeting IPF
Discover how collagen hybridizing peptides (CHPs) outperform Masson's trichrome in detecting collagen in idiopathic pulmonary fibrosis (IPF) tissues.
View Details
Revolutionizing Cardiovascular Disease Diagnosis: How Collagen Hybridizing Peptides Unveil Hidden Arterial Damage
Discover how Collagen Hybridizing Peptides (CHPs) transform the diagnosis and treatment of cardiovascular diseases by accurately identifying and targeting damaged arterial collagen. Learn about this innovative technology and its impact on improving patient outcomes.
View Details
Liver fibrosis Detected with CHPs in half the time it takes with Picrosirius Red
Collagen Hybridizing Peptides (CHPs) revolutionize liver fibrosis detection by halving biopsy analysis time. Explore detailed insights into collagen remodeling and deposition, which is directly linked to fibrotic activity.
View Details
CHPs’ can Help Predict Liver Survival in Biliary Atresia
Biliary Atresia (BA) is a severe liver disease in infants, often leading to cirrhosis and death. Collagen Hybridizing Peptides (CHP) offer diagnostic and prognostic insights, aiding treatment decisions and organ transplant allocation.
View Details